Korean J Hepatol.
2008 Sep;14(3):411-416. 10.3350/kjhep.2008.14.3.411.
Entecavir 1 mg therapy for lamivudine-refractory chronic hepatitis B
- Affiliations
-
- 1Department of Internal Medicine, Chung-Ang University School of Medicine, Seoul, Korea. mdjoon@cau.ac.kr
- KMID: 1381473
- DOI: http://doi.org/10.3350/kjhep.2008.14.3.411
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
- Experience with Entecavir Therapy for Lamivudine-Resistant Chronic Hepatitis B in Korean Children and Adolescents
- Efficacy of New Anti-viral Agent in the Treatment of Chronic Hepatitis B
- Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients
- Lamivudine: fading into the mists of time
